Equity

IBB

iShares Biotechnology ETF

Overview

Important Information: Capital at Risk. The value of investments and the income from them can fall as well as rise and are not guaranteed. Investors may not get back the amount originally invested.

Loading

Performance

Performance

Chart

View full chart

Distributions

Record Date Ex-Date Payable Date
View full table

This chart shows the fund's performance as the percentage loss or gain per year over the last 10 years.

  2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Total Return (%) 34.1 11.5 -21.5 21.2 -9.1 24.8 25.9 1.0 -13.6 3.6
Benchmark (%) 34.4 11.8 -21.3 21.6 -8.9 25.1 26.4 1.4 -13.3 4.0
  From
30-Sept-2019
To
30-Sept-2020
From
30-Sept-2020
To
30-Sept-2021
From
30-Sept-2021
To
30-Sept-2022
From
30-Sept-2022
To
30-Sept-2023
From
30-Sept-2023
To
30-Sept-2024
Total Return (%)

as of 30/Sept/2024

36.38 19.59 -27.36 4.75 19.42
Benchmark (%)

as of 30/Sept/2024

36.90 20.06 -27.09 5.10 19.80
  1y 3y 5y 10y Incept.
19.42 -3.14 8.18 5.03 6.62
Benchmark (%) 19.80 -2.81 8.57 5.37 6.97
  YTD 1m 3m 6m 1y 3y 5y 10y Incept.
7.45 -1.65 6.23 6.21 19.42 -9.14 48.19 63.35 355.28
Benchmark (%) 7.68 -1.62 6.28 6.36 19.80 -8.20 50.87 68.72 391.89

Key Facts

Key Facts

Net Assets of Fund
as of 04/Oct/2024
USD 7,462,710,710
Exchange
NASDAQ
Benchmark Index
NYSE Biotechnology Index
SFDR Classification
Other
Premium/Discount
as of 04/Oct/2024
0.08
ISA Eligibility
No
Volume - 1d
as of 04/Oct/2024
650,133.00
Fund Launch Date
05/Feb/2001
Asset Class
Equity
Index Ticker
ICEBIOT
Distribution Frequency
Quarterly
CUSIP
464287556
UK Reporting Status
No

Portfolio Characteristics

Portfolio Characteristics

Number of Holdings
as of 04/Oct/2024
214
12 Month Trailing Dividend Distribution Yield
as of 31/Aug/2024
0.27
P/E Ratio
as of 04/Oct/2024
24.64
Equity Beta (3y)
as of 31/Aug/2024
0.78
Standard Deviation (3y)
as of 31/Aug/2024
19.12
P/B Ratio
as of 04/Oct/2024
4.15

Fees

Fees

as of current prospectus
Management Fee 0.45
Acquired Fund Fees and Expenses 0.00
Foreign Taxes and Other Expenses 0.00
Gross Expense Ratio 0.45

Ratings

Ratings

Morningstar Medalist Rating

Morningstar Medalist Rating - BRONZE
Morningstar has awarded the Fund a Bronze medal. (Effective 31/Aug/2024)
Analyst-Driven % as of 31/Aug/2024
20.00
Data Coverage % as of 31/Aug/2024
100.00

Registered Locations

Registered Locations

  • Finland

  • Netherlands

  • Sweden

  • United Arab Emirates

  • United Kingdom

Holdings

Holdings

Issuer Ticker Name Sector Asset Class Market Value Weight (%) Notional Value Nominal CUSIP ISIN SEDOL Price Location Exchange Currency FX Rate Accrual Date
Detailed Holdings and Analytics contains detailed portfolio holdings information and select analytics.



The values shown for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Holdings data shown reflects the investment book of record, which may differ from the accounting book of record used for the purposes of determining the Net Assets of the Fund. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The calculated values may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent date for which a price is available and may not necessarily be as of the date shown above.

Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures.

Exposure Breakdowns

Exposure Breakdowns

as of 04/Oct/2024

% of Market Value

Type Fund
Allocations are subject to change.

Listings

Listings

Exchange Ticker Currency Listing Date SEDOL Bloomberg Ticker
NASDAQ IBB USD 05/Feb/2001 - IBB
Bolsa Mexicana De Valores IBB MXN 30/Jun/2009 B3M0Q77 IBB* MM
Santiago Stock Exchange IBB CLP 23/Oct/2017 - -

Literature

Literature